NCT01583218 2023-08-07APEXAlexion Pharmaceuticals, Inc.Phase 3 Completed7,513 enrolled 18 charts 1 FDA
NCT01839487 2020-07-20PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic CancerHalozyme TherapeuticsPhase 2 Completed279 enrolled 19 charts